Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
Jin Young Ahn(Yonsei University), Yujin Sohn(Yonsei University), Su Hwan Lee(Yonsei University), Yunsuk Cho(Yonsei University), Jong Hoon Hyun(Yonsei University), Yae Jee Baek(Yonsei University), Su Jin Jeong(Yonsei University), Jung Ho Kim(Yonsei University), Nam Su Ku(Yonsei University), Joon‐Sup Yeom(Yonsei University), Juhye Roh(Yonsei University), Mi Young Ahn(Seoul Medical Center), Bum Sik Chin(National Medical Center), Young Sam Kim(Yonsei University), Hyukmin Lee(Yonsei University), Dongeun Yong(Yonsei University), Hyun Ok Kim(Yonsei University), Sinyoung Kim(Yonsei University), Jun Yong Choi(Yonsei University)
Cited by 370Open Access
Abstract
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.